Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AFYA
Upturn stock ratingUpturn stock rating

Afya Ltd (AFYA)

Upturn stock ratingUpturn stock rating
$17.86
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: AFYA (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

9 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $20.39

1 Year Target Price $20.39

Analysts Price Target For last 52 week
$20.39Target price
Low$14.33
Current$17.86
high$19.9

Analysis of Past Performance

Type Stock
Historic Profit -40.99%
Avg. Invested days 23
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.59B USD
Price to earnings Ratio 13.11
1Y Target Price 20.39
Price to earnings Ratio 13.11
1Y Target Price 20.39
Volume (30-day avg) 9
Beta 0.6
52 Weeks Range 14.33 - 19.90
Updated Date 06/30/2025
52 Weeks Range 14.33 - 19.90
Updated Date 06/30/2025
Dividends yield (FY) 1.32%
Basic EPS (TTM) 1.34

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 19.79%
Operating Margin (TTM) 39.79%

Management Effectiveness

Return on Assets (TTM) 8.16%
Return on Equity (TTM) 16.81%

Valuation

Trailing PE 13.11
Forward PE 10.71
Enterprise Value 1965274921
Price to Sales(TTM) 0.46
Enterprise Value 1965274921
Price to Sales(TTM) 0.46
Enterprise Value to Revenue 3.13
Enterprise Value to EBITDA 7.28
Shares Outstanding 46586100
Shares Floating 7491784
Shares Outstanding 46586100
Shares Floating 7491784
Percent Insiders 68.11
Percent Institutions 17.91

Analyst Ratings

Rating 3
Target Price 20.39
Buy 2
Strong Buy 1
Buy 2
Strong Buy 1
Hold 2
Sell 1
Strong Sell 3
Strong Sell 3

ai summary icon Upturn AI SWOT

Afya Ltd

stock logo

Company Overview

overview logo History and Background

Afya Ltd. was founded in 2019, consolidating several medical education institutions in Brazil. It has grown rapidly through acquisitions and organic expansion, becoming a leading player in medical education and related services.

business area logo Core Business Areas

  • Undergraduate Medical Education: Offers undergraduate medical degrees through its network of campuses in Brazil.
  • Continuing Medical Education: Provides continuing education and specialization courses for medical professionals.
  • Digital Health Services: Offers digital health solutions, including telemedicine and practice management tools.

leadership logo Leadership and Structure

The leadership team consists of experienced executives in education, healthcare, and finance. The organizational structure is designed to manage its geographically dispersed campuses and diverse business units.

Top Products and Market Share

overview logo Key Offerings

  • Undergraduate Medical Degrees: Afya's core offering, providing full medical degrees. Market share data is fragmented across various regions in Brazil, but Afya holds a significant portion, estimated at around 20% overall. Competitors include Estu00e1cio, Unip, and other regional medical schools. Revenue is the largest portion of their overall revenue.
  • Specialization Programs: Post-graduate medical education programs. The market is highly competitive with many providers. Revenue from this segment is growing, but smaller compared to the core undergraduate revenue. Competitors include MedCof and other specialized medical education providers.
  • Digital Health Platform iClinic: Software as a service platform for physicians in Brazil with tools like EHR and scheduling tools. They have over 30,000 active users. There is not much market data. Competitors include Memed, Doctoralia, and Feegow.

Market Dynamics

industry overview logo Industry Overview

The Brazilian medical education market is growing, driven by increasing demand for healthcare professionals and limited access to quality education. The market is fragmented, with a mix of private and public institutions.

Positioning

Afya Ltd. is positioned as a premium provider of medical education, focusing on quality and innovation. It has a competitive advantage through its established brand, extensive network, and integrated digital platform.

Total Addressable Market (TAM)

The TAM for medical education in Brazil is estimated to be in the billions of USD annually. Afya is well-positioned to capture a significant share of this market through organic growth and acquisitions.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition
  • Extensive network of campuses
  • Integrated digital platform
  • Experienced management team
  • Proven track record of acquisitions

Weaknesses

  • Geographic concentration in Brazil
  • Reliance on government regulations
  • Potential for increased competition
  • High capital expenditure requirements
  • Dependence on accreditation for programs

Opportunities

  • Expansion into new geographic markets within Brazil
  • Development of new digital health solutions
  • Acquisition of complementary businesses
  • Partnerships with hospitals and healthcare providers
  • Growing demand for telemedicine solutions

Threats

  • Changes in government regulations
  • Increased competition from other medical schools
  • Economic downturn in Brazil
  • Currency fluctuations
  • Negative impact on enrollment due to global events

Competitors and Market Share

competitor logo Key Competitors

  • Estu00e1cio (YDUQ3.SA)
  • u00c2nima Educau00e7u00e3o (ANIM3.SA)
  • Ser Educacional (SEER3.SA)

Competitive Landscape

Afya has an advantage with a strong focus on medical education and its integrated digital platform. Competitors are larger, more diversified education companies.

Major Acquisitions

MedCof

  • Year: 2020
  • Acquisition Price (USD millions): 270
  • Strategic Rationale: Strengthen Afya's postgraduate medical education offerings.

iClinic

  • Year: 2019
  • Acquisition Price (USD millions): 32
  • Strategic Rationale: Expand Afya's digital health ecosystem.

Growth Trajectory and Initiatives

Historical Growth: Afya Ltd. has experienced rapid growth through acquisitions and organic expansion since its inception.

Future Projections: Analysts project continued growth for Afya Ltd., driven by increasing demand for medical education and the company's expansion into new markets.

Recent Initiatives: Afya Ltd. has recently focused on expanding its digital health platform and acquiring new medical education institutions.

Summary

Afya Ltd. is a growing medical education company in Brazil with a strong brand and integrated digital platform. Its acquisition strategy has fueled rapid expansion, but reliance on Brazil exposes it to economic and regulatory risks. Growth is projected to continue, particularly in digital health, however increased competition is a factor to monitor. Overall, Afya is well-positioned, but needs to diversify geographically and manage its debt effectively.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • Analyst Reports
  • Market Research Reports

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a financial professional.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Afya Ltd

Exchange NASDAQ
Headquaters Nova Lima, MG, Brazil
IPO Launch date 2019-07-19
CEO -
Sector Consumer Defensive
Industry Education & Training Services
Full time employees -
Full time employees -

Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. In addition, it offers printed and digital content, as well as an online medical education platform and practical medical training services. Further, the company offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics, and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. Afya Limited was founded in 1999 and is headquartered in Nova Lima, Brazil.